Evidence map›Paper›PMID 30983050›Full record

ArticleXenotransplantation2019

Predictive biomarkers for graft rejection in pig-to-non-human primate corneal xenotransplantation.

Chang Ho Yoon, Se Hyun Choi, Hyun Ju Lee, Hee Jung Kang, Mee Kum Kim

Open access · greenAbstract readComparative Study
In one paragraph

Article in Xenotransplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Immunology and Donor-Specific Antibodies in Corneal Transplantation.Archivum immunologiae et therapiae experimentalis · 2021
    Review
  5. Article
  6. Corneal xenotransplantation: Where are we standing?Progress in retinal and eye research · 2021
    Review
  7. CD4Xenotransplantation · 2020
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Chang Ho YoonDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0003-2203-5709
Se Hyun ChoiDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-9916-0332
Hyun Ju LeeLaboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Seoul, Republic of Korea.ORCID 0000-0001-7022-4331
Hee Jung KangDepartment of Laboratory Medicine, Hallym University College of Medicine, Anyang-si, Republic of Korea.ORCID 0000-0003-1249-6181
Mee Kum KimDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0001-7850-6894
Seoul National University · KRHallym University · KRSeoul National University Hospital · KR

Funding

Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
Resource for Nonhuman Primate Cell Depleting AntibodiesR24OD010976 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ENGELMAN, KATHLEEN, MAGNANI, DIOGO · 2012 to 2019
$4.7M
NIAID NIH HHS HHSN272200900037CNIAID NIH HHS U24 AI126683NIH HHS R24 OD010976
6 · The paper itself

Abstract

We investigated the predictive biomarkers for graft rejection in pig-to-non-human primate (NHP) full-thickness corneal xenotransplantation (n = 34). The graft score (0-12) was calculated based on opacity, edema, and vascularization. Scores ≥ 6 were defined as rejection. NHPs were divided into two groups: (a) graft rejection within 6 months; and (b) graft survival until 6 months. In the evaluation of 2-week biomarkers, none of the NHPs showed rejection within 2 weeks and the 34 NHPs were divided into two groups: (a) entire rejection group (n = 16); and (b) survival group (n = 18). In the evaluation of 4-week biomarkers, four NHPs showing rejection within 4 weeks were excluded and the remaining 30 NHPs were divided into two groups: (a) late rejection group (n = 12); and (b) survival group (n = 18). Analysis of biomarker candidates included T/B-cell subsets, levels of anti-αGal IgG/M, donor-specific IgG/M from blood, and C3a from plasma and aqueous humor (AH). CD8

Indexed as

Corneal TransplantationAnimalsAntibodies, HeterophileBiomarkersComplement ActivationComplement C3aGraft RejectionHeterograftsImmunoglobulin GImmunoglobulin MImmunosuppressive AgentsLymphocyte CountLymphocyte SubsetsMacaca mulattaPredictive Value of TestsRetrospective StudiesAntibodies, HeterophileBiomarkersComplement C3aImmunoglobulin GImmunoglobulin MImmunosuppressive AgentsbiomarkerC3aCD8+IFNγ+ cellscornearejectiontransplantationxenotransplantation

Identifiers

PMID30983050
PMCPMC6717035
OpenAlexW2935697335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.